Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
ABSTRACT Background: Epilepsy affects about 50 million people worldwide and around 30% of these patients have refractory epilepsy, with potential consequences regarding quality of life, morbidity and premature mortality. Objective: The aim of treatment with antiseizure medications (ASMs) is to a...
Saved in:
| Main Authors: | Maria Luiza Giraldes de MANREZA, Tatiane Amaral PAN, Eduardo Quinalha CARBONE, Antonio Carlos Amedeo VATTIMO, Renata HERRERA, Douglas Costa MORAIS, Rita Antonelli CARDOSO, Glenda Corrêa Borges de LACERDA, Katia LIN, Frederico Nakane NAKANO, Pedro André KOWACS, André Luis Fernandes PALMINI, Adélia Maria de Miranda Henriques SOUZA, Stevin ZUNG, Elza Márcia Targas YACUBIAN |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
2021-06-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2021000400290&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phenytoin versus Levetiracetam for Prevention of Early Posttraumatic Seizures: A Prospective Comparative Study
by: Kairav S. Shah, et al.
Published: (2015-11-01) -
Study protocol of short versus long-term levetiracetam in brain tumors (LIBRA): a phase 3 randomized controlled trial
by: Archya Dasgupta, et al.
Published: (2025-05-01) -
Levetiracetam as an Alternative to Phenytoin for Prophylactic Use in Post-Traumatic Seizures: a Literature Review
by: Gabriela Nagatri, et al.
Published: (2024-10-01) -
Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double‐blind placebo‐controlled crossover trial
by: Arjune Sen, et al.
Published: (2024-12-01) -
Levetiracetam versus phenytoin/fosphenytoin for second-line treatment of children with convulsive status epilepticus: an up-to-date meta-analysis and systematic review of randomized controlled trials
by: Linping Jin, et al.
Published: (2025-05-01)